Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling

Table 1

Distribution of Eya2 status in prostate cancer according to clinicopathological characteristics.

Characteristics	Number of patients	Eya2 low expression	Eya2 high expression	P
Age
<65	39	10	29	0.2288
≥65	59	22	37
TNM stage
I-II	53	24	29	0.0038
III-IV	45	8	37
Gleason score
≤7	29	14	15	0.0128
>7	66	15	51
T stage
T1-T2	69	28	35	0.0008
T3-T4	35	4	31
Lymph node metastasis
Absent	71	23	48	0.4965
Present	24	6	18